The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey
- 143 Downloads
The economic effect of regular follow-up and early management in patients with early chronic obstructive pulmonary disease (COPD) has not yet been clarified. Therefore, this study aimed to estimate the economic effect of regular follow-up and early management in these patients.
Patients with early COPD were identified from the Korea National Health and Nutrition Examination Survey. We analyzed medical utilization and cost for 2 years without any missing data by using the Korean National Health Insurance data. Patients with routine healthcare maintenance were defined as, after diagnosis, those with regular visits to the hospital and receiving early management of COPD.
Among 1204 patients with early COPD, the patients who were classified as the group with routine healthcare maintenance (69/146; 47.3%) and the group with intermittent healthcare user (79/1058; 7.5%) visited to hospital for the next 2 years. The patients with routine healthcare maintenance had lower cost of inpatient service and frequencies of emergency room (ER) visit and intensive care unit (ICU) admission than intermittent healthcare users (cost of inpatient service, $4595 vs. $4953 per person; ER visit, 7.2 vs. 11.5; ICU admission, 4.3 vs. 7.7). Even in patients with COPD and FEV1 ≥ 80, early intervention through follow-up reduced the cost of inpatient service because these patients could have had less severe acute exacerbations than intermittent healthcare users.
Patients with early COPD, even those with FEV1 ≥ 80, need regular follow-up for early management and disease control as well as for reducing the socioeconomic burden of the disease.
KeywordsChronic obstructive pulmonary disease Korea Early intervention Economics
Chronic obstructive pulmonary disease
Forced expiratory volume in 1 s
Forced vital capacity
The Korea National Health and Nutrition Examination Survey
The Korean National Health Insurance
Pulmonary function test
The International Classification of Diseases-Tenth Revision
Intensive care unit
This study was supported by a Grant (No. 2014P3300300) from the Korea Centers for Disease Control and Prevention. This study was supported by COPD cohort data of HIRA.
LYS, MKH, YKH: Conception and design of the study; LYS, MKH, RCK, JKS, YKH: Data generation (When applicable); LYS, MKH, RCK, KYH, LSY, USJ, LCH, JKS, YKH: Analysis and Interpretation of the data; LYS, MKH, RCK, KYH, LSY, USJ, LCH, JKS, YKH: Preparation or critical revision of the manuscript.
This study was supported by a grant (2014P3300300) from the Korea Centers for Disease Control and Prevention.
Compliance with Ethical Standards
Conflict of interest
The authors of this study declare that they have no competing interests in regard to this manuscript.
- 1.Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, Yoon HI, Lim SC, Park JY, Park SJ, Seo KH, Kim KU, Oh YM, Lee NY, Kim JS, Oh KW, Kim YT, Park IW, Lee SD, Kim SK, Kim YK, Han SK (2011) Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 16(4):659–665CrossRefGoogle Scholar
- 2.Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 195(5):557–582CrossRefGoogle Scholar
- 19.Kim J, Rhee CK, Yoo KH, Kim YS, Lee SW, Park YB, Lee JH, Oh Y, Lee SD, Kim Y, Kim K, Yoon H (2013) The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. Int J Chron Obstruct Pulm Dis 8:561–568Google Scholar
- 23.Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRefGoogle Scholar
- 25.Bahk J, Kim YY, Kang HY, Lee J, Kim I, Lee J, Yun SC, Park JH, Shin SA, Khang YH (2017) Using the National Health Information Database of the National Health Insurance Service in Korea for monitoring mortality and life expectancy at national and local levels. J Korean Med Sci 32(11):1764–1770CrossRefGoogle Scholar
- 26.NHIS Available from: https://www.nhis.or.kr/static/html/wbd/g/a/wbdga0101.html. Accessed 22 July 2018
- 31.Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ (2017) Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med 195(3):324–330Google Scholar
- 35.Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK (2015) Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147(4):894–942CrossRefGoogle Scholar
- 37.Pavord ID, Jones PW, Burgel PR, Rabe KF (2016) Exacerbations of COPD. Int J Chron Obstruct Pulm Dis 11(Spec Iss):21–30Google Scholar
- 39.Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JH, Grenier PA, Kauczor HU, Bailey WC, DeMeo DL, Casaburi RH, Friedman P, Van Beek EJ, Hokanson JE, Bowler RP, Beaty TH, Washko GR, Han MK, Kim V, Kim SS, Yagihashi K, Washington L, McEvoy CE, Tanner C, Mannino DM, Make BJ, Silverman EK, Crapo JD (2015) Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 175(9):1539–1549CrossRefGoogle Scholar
- 40.Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gouskova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ, Paine R III, Rennard S, Tashkin DP, Han MK (2016) Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 374(19):1811–1821CrossRefGoogle Scholar
- 41.Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 7(5):e37483CrossRefGoogle Scholar
- 43.Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB (2013) Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988–1994 to 2007–2010. Chest 143(5):1395–1406CrossRefGoogle Scholar
- 44.Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J (2015) Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 373(2):111–122CrossRefGoogle Scholar